Food grade Anti aging Nicotinamide Mononucleotide NMN Beta-NMN Powder with certificated GMP

Carton size:40*25*20cm In bulk:200mg/500mg,Each carton is 1500pcs; Blister:300mg/500mg/1000mg,Count 10/12/15 grains per foil blister; Bottling:300mg/500mg/1000mg,Count 30/60/90 grains per plastic bottle; Other package customized is available.

Contact us:  

MS.Reiko Cao

Wechat:18034525878

Cellphone:(+86)18034525878

E-mail:reiko@jnfelicity.com

Web:

Jinan Felicity Biotechnology Co., Ltd.

Felicity Biotech Limited covers an area of 50 hectares, we have more than 6000 employees.We have five soft capsule production line, the production line of three, two jelly production line, the powder production line and the two oral liquid production line, GMP quality management certification, CGMP, HACCP, ISO9001, ISO14001, OHASAS18001 BRC global OEM, wholesale and retail.

We guarantee:

1.Mainly provide innovative and advanced production facilities

2.More than 1500 empirical formula date base

3.Well-equipped chemical analysis laboratory run 40 trained professionals

4.Professional sales team to support routines and formula of people understand your business brand

5.On time delivery

6.The quality of the product

7.A cost-effective production

Felicity Biotech Limited is a company specializing in the production, will understand your needs and willingness and ability to meet them.We will try to understand your concerns, we will implement a plan, to meet your requirements.We want to make you happy.

NMN(nicotinamide mononucleotide)

And at Japan's keio university joint research team at the university of Washington in the United States announced on July 11,2016, they have officially begun using nicotinamide single nucleotide (NMN) in human clinical trials.NMN in animal experimentsconfirmed with reverse part such as neural tissues of aging effect.The study is one of the world's first test NMN drugs on thehuman body, if you would be able to confirm its safety, that NMN in the future will be more widely used in the field of diseaseprevention and treatment of aging.And at Japan's keio university joint research team at the university of Washington in the United States announced on July 11,2016, they have officially begun using nicotinamide single nucleotide (NMN) in human clinical trials.NMN in animal experimentsconfirmed with reverse part such as neural tissues of aging effect.The study is one of the world's first test NMN drugs on the human body, if you would be able to confirm its safety, that NMN in the future will be more widely used in the field of diseaseprevention and treatment of aging.